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Abstract 
 Every year, the fungal pathogen Cryptococcus neoformans infects roughly 1 million 
people and results in over 600,000 deaths worldwide. This opportunistic pathogen is the leading 
cause of death for patients who are immunocompromised, including individuals with HIV/AIDS. 
Upon infection with C. neoformans, the development of a Th1 immune response is critical for 
fungal clearance. TNFα, a pro-inflammatory cytokine, has been shown to be critical to the 
priming of dendritic cells (DCs) that train the appropriate action of T-cells. We explored the 
mechanism behind the interaction between TNFα and DCs, specifically, to determine if TNFα 
induces changes on the epigenetic level in DCs. By examining genes critical to the mounting of 
the Th1 response, we found that depletion of TNFα leads to higher expression of DC2 genes and 
a more Th2 polarized response. This corresponds to higher levels of global repression, indicated 
by epigenetic marker H3K27me3, and higher levels of histone methyltransferase EZH2. Because 
epigenetic modifications are the means by which immune cells “remember” to express or not to 
express certain genes, we concluded that TNFα plays a critical role in programing DC function 
during cryptococcal infection. Specifically, our data showed that TNFα prevented repressive 
epigenetic modifications on DC1 genes, contributing to the “DC1 training” of DCs necessary for 
induction of the protective T-cell mediated immune response. After analyzing which DC genes 
were associated with this repressive modification, we found the key DC1 gene IL-12b had been 
repressed upon depletion of TNFα. Our findings have shed light on the effects of this cytokine in 
the immune response to C. neoformans infection and may have broader implications regarding 
the mechanisms by which DCs are trained to execute certain type of functional training in hosts 
upon infection with a variety of pathogens.   
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Introduction  
Cryptococcus neoformans 
Every year, Cryptococcus neoformans (C. neo), an opportunistic fungal pathogen, infects 
over 1 million people every year and leads to fatality in over 600,000 patients [1]. Currently, C. 
neo is the leading cause of fatal fungal infection among immunodeficient hosts, including people 
who are infected with HIV/AIDS [2, 3]. C. neo is a common environmental yeast found in tree 
bark and pigeon excreta ; inhalation of spores or desiccated yeast into the lungs is thought to be 
the route of infection [4-6]. The yeast is able to reproduce by budding and is non-filamentous in 
hosts [7]. Upon infection, the yeast then lodges in the patient’s alveoli, and without a protective 
immune response, leads to dissemination to the central nervous system (CNS) [8]. Infection with 
C. neo can also be latent or persistent over time, and can cause symptoms of the infection to 
recur if the immune system becomes compromised [9, 10].  
The Immune Response 
T-helper cell mediated immunity is required for clearance of C. neo. In the absence of a 
protective immune response, C. neo is able to disseminate from the lungs to the CNS, which can 
result in meningitis and can be fatal to the host [1].  
A. The Innate Immune System 
Upon infection, the host’s innate immune system must decide how the more productive 
method to proceed to lead to fungal clearance. The exterior surface of the fungal pathogen 
contains pathogen associated molecular patterns (PAMPs) [11], which can be recognized by 
various host cells. Many types of cells, including macrophages and dendritic cells (DCs), natural 
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killer (NK) cells, and neutrophils, are able to recognize these PAMPs by pattern recognition 
receptors (PRRs) on their surface [12]. Upon recognition of infection of C. neo, an immune 
response is activated.  
DCs and macrophages are known as antigen presenting cells (APCs) because they are 
able to process antigens and present these molecules on their surface. More specifically, DCs are 
known as “professional APCs” because of their abilities to signal to T-cells and stimulate an 
adaptive response. DCs express the integrin CD11c on their surface, which is a transmembrane 
protein that can be used experimentally to identify DC populations [13]. Upon the phagocytosis 
of C. neo, DCs process the pathogen and load the antigen onto major histocompatibility 
complexes (MHCs), which are then shuttled to the cell surface to be presented to T-cells [14]. 
MHC molecules are split up into Class I and II depending on which T-cell molecule bind they 
bind with at a higher affinity (CD8 and CD4 respectively). After phagocytosis of the pathogen, 
DCs go through a process of maturation and polarization, during which they up-regulate 
expression of MHC II, surface receptors, co-stimulatory molecules, and cytokines. DCs then 
migrate to the draining lymph nodes, where these specific “patterns” of cell-bound and soluble 
signals expressed by DCs directs the development of specific T-cell responses [15].  
B. The Adaptive Immune System 
 Effective clearance of C. neo relies on the development of a Th1 type response [16-18]. 
T-cells can be polarized in a variety of ways to have differential responses, some of which 
include Th1, Th2, Th17 and T-reg [19]. T-cells producing the cytokines IFNγ, TNFα, or IL-17, 
known as Th1 and Th17 respectively, are necessary for protective immunity to C. neo [17, 18, 
20, 21]. Conversely, T-cells producing IL-4, known as a Th2 response, are ineffective for 
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clearance of the infection [17, 22-25]. Professional APCs, or DCs, are critical for priming the T-
cell immune response; DC priming Th1/Th17 responses are termed DC1, while DC priming Th2 
responses are DC2. DC1s are characterized by robust iNOS expression, whereas the DC2s that 
prime a non-protective Th2 response are characterized by expression of Gal3, Fizz1, IL-5 and 
IL-13[15]. 
 Three signals are necessary for the DC to effectively prime the naïve T-cell [19]. The first 
is the interaction between the MHC and the T-cell receptor (TCR). This requires the high affinity 
binding of the TCR and the presence of either glycoprotein CD8 or CD4 from the T-cell with the 
MHC Class I or II on the DC loaded with an antigen. The second required signal is between co-
stimulatory molecules CD40 and CD80/86 on the DC and CD40L and CD28 on the T-cell. Lack 
of CD40 or CD80/86 on the DC halts the priming and activation of T-cells. The third necessary 
signal is the cytokines released from the DC, some of which include IL-12, IL-6, TGF-β and IL-
4. Higher levels of CD40, CD80/86 and MHCII on DCs are necessary for proper protective T-
cell stimulation (reviewed in [26]). 
Tumor Necrosis Factor Alpha (TNFα) 
The pro-inflammatory cytokine TNFα acts in DCs by signaling through the MAPK and 
NFΚB pathways [27]. Previous experiments have shown that defects in TNFα signaling early 
during the DC-dependent phase of C. neo infection results in non-protective immunity [28-31]. 
Transient depletion of cytokine TNFα, which is normally produced by the host during protective 
response to C. neoformans, results in a development of non-protective response. These negative 
effects of early depletion remain even after levels of TNFα recover in about a week post anti-
TNFα administration [28-31]. 
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It has been previously established that immunotherapy with antibodies against TNFα 
used as treatment for rheumatoid arthritis lead to increased burden of a variety of fungal 
infections [32, 33]. TNFα blockers, including adalimumab, etanercept, and infliximab, are used 
in humans to treat autoimmune diseases, including rheumatoid arthritis [34]. Adalimumab was 
approved by the FDA approved in 2002 for rheumatoid arthritis, psoriatic arthritis, ankylosing 
spondylitis, plaque psoriasis, Crohn’s, Ulcerative Colitis, moderate to severe chronic psoriasis, 
and juvenile idiopathic arthritis [35]. Other TNFα blockers have also been found to treat diseases 
including ankylosing spondylitis and plaque psoriasis [36]. These TNFα blockers work through a 
variety of methods, which including blocking the TNFα Receptors (TNFRI and TNFRII), or by 
blocking soluble and membrane-bound TNFα [34].  
Other immunocompromised individuals are highly susceptible to C. neo infection 
because they are not able to make successful TNFα signaling [37]. However, some of the more 
virulent strains of C. neo are able to suppress the TNFα response even in immunocompetent 
hosts, causing a non-protective immune response and dissemination to the CNS [38].  
 
Epigenetic Modifications 
Studies on epigenetic changes to DNA and histone proteins are becoming increasingly 
popular to explain gene expression. Modifications to histone proteins at the gene promoter region 
serve as a mechanism by which cells “remember” to express or to not express specific genes 
[39]. Histone protein complexes are comprised of a clustered group of eight similar protein 
structures, which DNA can wrap around. They are comprised of two of each of the segments 
H2A, H2B, H3 and H4, to create an octamer. Each segment has multiple tails that help to control 
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how tightly DNA is wrapped around the protein structure. These tails contain many positively-
charged amino acids, including lysine (K) and arginine (R) in order to adhere to the negatively 
charged phosphate backbone of DNA (reviewed in [40]).  
Various molecules added to the histone tails affect how tightly DNA is wrapped around 
the histone proteins. For example, acylation of histone proteins creates more space between the 
DNA and protein, allowing for easier access by transcription factors (TFs) and allows for more 
gene expression [39]. Methylation can be either inhibitory or activating, depending on where it is 
deposited. Tri-methylation of Lysine 27 residue on Histone 3 (H3K27me3) is associated with 
gene repression [41], while similar modification at Lysine 4 residue (H3K4me3) is associated 
with increased levels of gene expression [42].  Histone methylation status is an outcome of 
enzymatic activities of methyltransferases and demethylases, responsible for the addition and 
removal of the methyl groups from histone tails, respectively [43]. EZH2 is a histone 
methyltransferase enzyme that inhibits gene expression via the addition of a tri-methyl group to 
H3K27 [44]. Conversely, MLL1 is a histone methyltransferase that facilitates gene activation by 
adding a tri-methyl group to H3K4 [45]. Enzymes such as EZH2 and MLL1 affect the specific 
gene promoter regions and have lasting effects on gene expression patterns. These changes to 
gene expression patters in turn affect translation of proteins critical for execution of specific cell 
functions [46].  
TNFα receptor signaling leading to epigenetic modification is poorly characterized, 
although some pioneering studies provide evidence of epigenetic signaling. TNFα receptors 
signal through multiple pathways, including NFΚB and MAPK pathways [27]. Signaling 
through the NFΚB pathway is known to lead to MLL1 activity [47]. Similarly, the MAPK 
pathway influences EZH2 action [48].  
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 In this study, our aim was to determine if TNFα signaling affects the repressive motif 
H3K27me3 if this contributes to “training” of DCs towards either DC1 or DC2. Because TNFα 
is associated with a Th1 immune response, we hypothesize that TNFα prevents repressive 
modification H3K27me3 at DC1 gene promoter regions. Since DC1 or DC2 polarization directly 
influences the priming of the T-cell response into Th1 or Th2 (protective or non-protective 
against infection of C. neo), a greater understanding of this mechanism could gain insight into 
potential targets for therapies or treatments.  
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Materials and Methods 
Cryptococcus neoformans 
The 52D strain obtained form the American Type Culture Collection (ATCC 24067) of 
Cryptococcus neoformans was used for our experiments. The pathogen was recovered from 
frozen stocks stored at -80°C with 10% glycerol. It was cultured to log phase at 37°C in 
Sabouraud dextrose broth (1% neopeptone, 2% dextrose; Difco, Detroit, MI) on a shaker. The 
cultures were then washed in non-pyrogenic saline (Travenol, Deerfield, IL), counted on a 
hemocytometer, and diluted to 3.3 ×105 yeast cells/mL in sterile non-pyrogenic saline. 
Animals 
Female CBA/J Mice obtained from Jackson Laboratories (Bar Harbor, ME) were used for our 
studies. Mice were housed under pathogen-free conditions and enclosed in filter-top cages. The 
mice were aged between 8-10 weeks at the time of infection with Cryptococcus neoformans, or 
12 weeks at the time of bone marrow isolation. Animals were humanely euthanized using CO2 
inhalation. The University Committee on the Use and Care of Animals and the Veterans 
Administration Institutional Animal Care and Use Committee approved all experiments. 
Intratracheal Inoculation 
Mice were anesthetized via intraperitoneal injection of Ketamine and Xylazine (100 and 6.8 
mg/kg body weight, respectively) and were restrained on a foam plate using tape. A small 
incision was made through the skin covering the trachea, and the underlying salivary glands and 
muscles were separated. Infection was performed by intratracheal injection of 30 µL (104 CFU) 
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via 30-gauge needle actuated from a 1-ml tuberculin syringe with C. neoformans suspension (3.3 
×105 /mL). The skin was then closed with cyanoacrylate adhesive. Mice were monitored, placed 
under a heat lamp, and given artificial tears during recovery from anesthesia. The animals 
recovered with minimal visible trauma. Following infection, the inoculum were cultured and 
plated for CFU (Colony Forming Units) to confirm the number of organisms injected into the 
mice.  
Anti-TNFα Injection 
Mice received treatment with either an anti-TNFα antibody (100 ng/mouse, Taconic, Hudson, 
NY) or non-specific IgG (vehicle) as a control prior to infection with C. neoformans. Mice 
received injections of 20 µL via intra-peritoneal route at day 0. 
Lung Leukocyte Isolation 
Lungs were perfused free of peripheral blood cells with PBS. The perfused lungs were then 
excised, washed with RPRMI, minced with scissors, and dissociated by gentleMACS tissue 
dissociator (Miltenyi Biotec, Cambridge, MA). Dissociated samples were digested enzymatically 
in an incubator at 37°C for 35 min in 10 mL/mouse of digestion buffer [RPMI, 5% FBS, 
penicillin and streptomycin (Invitrogen, Grand Island, NY); 1 mg/ml collagenase A (Roche 
Diagnostics, Indianapolis, IN); and 30 µg/mL DNase (Sigma, St. Louis, MO)], and then 
dissociated a second time more vigorously. An aliquot of the suspension was then removed for 
CFU. The samples were then centrifuged and re-suspended with RPMI. The cell suspension and 
tissue fragments were then further dissociated, centrifuged, and re-suspended with RPMI. 
Erythrocytes in the cell pellets were lysed by addition of 3 mL NH4Cl buffer (0.829% NH4Cl, 
0.1% KHCO3, and 0.0372% Na2EDTA, pH 7.4) for 3 minutes followed by a 10-fold addition of 
 13 
cold RPMI. Cells were pelleted and re-suspended in RPMI. The cell suspension and tissue 
fragments were then further dissociated by aspiration through a 10 mL syringe, followed by 
filtration through a sterile 100-µm nylon screen (Nitex, Kansas City, MO). The filtrate was 
centrifuged for 30 min at 3000 RPM in the presence of 20% Percoll (Sigma) to separate 
leukocytes from cell debris and epithelial cells. Leukocyte pellets were re-suspended in 5 mL 
complete RPMI media, and enumerated on a hemocytometer following dilution in Trypan Blue 
(Sigma, St. Louis, MO). 
Colony-Forming Unit Assay 
Spleens were removed from mice and cells were lysed with sterile DI water. For lungs, aliquots 
were collected during lung leukocyte digest (described above) to determine the fungal burden. 
10-fold serial dilutions of each sample were plated on Sabouraud dextrose agar plates in 
duplicates of 10-µl aliquots. Each plate incubated at room temperature for 3 days. C. neoformans 
colonies were counted 2 days later and the number of colony-forming units (CFU) was 
calculated on a per-organ basis. 
Pulmonary T-cell and Dendritic Cell Isolation 
108 lung leukocytes from each sample were exposed to a PE labeling reagent, incubated, exposed 
to EasySep PE Selection Cocktail, and incubated further (Stem Cell, Vancouver, BC). EasySep 
magnetic nanoparticles were added to attach to CD4+ cells (T-cells) and eluent was poured off. 
Cells were washed with 2% FBS in PBS 3 times, resuspended in buffer, centrifuged, and 
resuspended in Trizol. CD11c+ cells (DCs) were then isolated from the eluent via the same 
procedure, pelleted, and resuspended in Trizol. 
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Quantitative Real-Time PCR (qRT-PCR)   
RNA samples were isolated from Trizol using a phenol chloroform purification. Samples were 
separated from Trizol followed by purification with isopropanol. RNA was then quantified using 
a spectrophotometer. A Reverse Transcriptase (RT) reaction was preformed, which generated 
first-strand cDNA using RNeasy Plus Mini Kit (Invitrogen, Carlsbad, CA) according to the 
manufacturer's instructions using 500ng total mRNA per sample. qPCR was performed using an 
MX 3000P system (Stratagene, La Jolla, CA) according to the manufacturer's protocols. Forty 
cycles of PCR (94°C for 15 seconds followed by 60°C for 30 seconds and 72°C for 30 seconds) 
were performed on a cDNA template. The mRNA levels were normalized to beta-acctin levels 
and the ratio of sample to uninfected-baseline expression level (fold induction) was calculated 
for each sample. 
Cytometric Bead Array 
Serum was isolated from whole blood, and cytometric bead assays were performed according to 
the manufacturer’s protocol (BioLegand, San Diego, CA). After staining, the beads were run on 
an LSRII flow cytometer and analyzed with software provided by manufacturer. 
Flow Cytometry 
All staining reactions were performed according to the manufacturers' protocols. Data were 
collected on a FACS LSR II flow cytometer using FACSDiva software (BD Biosciences, San 
Jose, CA) and analyzed using FlowJo software (Tree Star, San Carlos, CA). 200,000 cells were 
analyzed per sample at a minimum. Gates were initially set based on light-scatter characteristics 
(side scatter and forward scatter) followed by gating on CD45+ population, then T-cells were 
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separated from myeloid cells by expression of CD3, CD4, CD8, CD11b, CD11c. Macrophages 
were distinguished from DCs by auto-fluorescence and CD11b expression. The total number of 
cells within each mouse tissue was calculated by multiplying the frequency of this population by 
the total number of leukocytes in each sample (percentage of cells multiplied by the original 
hemocytometer count of total cells). 
Isolation & Culture of Bone-Marrow Derived Dendritic Cells (BMDCs) 
Bone marrow cells were isolated from CBA/J female mice from tibias and femurs and flushed 
with a 5 mL of DMEM media per bone using a 1 mL syringe and a 25½-guage needle. Media 
contained DMEM [1g/L glucose + L-Glutamine + 110mg/L sodium pyruvate] 20% FBS, 1x 
GlutaMAX, 1x MEM nonessential amino acids, 1x sodium pyruvate, 20ng/mL GM-CSF, 100 
ug/mL streptomycin, 100 units/mL penicillin. Cells were dissociated by aspiration through a 10 
mL syringe, followed by filtration through a sterile 100-µm-nylon screen (Nitex, Kansas City, 
MO). The cells were then centrifuged, resuspended in the DMEM media and cultured in cells 
were cultured in 100 × 15-mm dishes at a concentration of 2 x 106 cells per dish. After 7 days, 
the loosely adherent BMDCs were removed and plated at a density of 1 x 106 cells/ml in 2 mls in 
a non-tissue-culture-treated 6-well dish. Cells were exposed to primary cytokine stimulations for 
24 hours, washed, and treated secondary cytokine stimulations for a subsequent 24 hours 
(described in Fig. 3 below). Following these sequences, BMDCs were removed via Trizol and 
processed for RNA and qRT-PCR. 
Chromatin Immunoprecipitation Assay 
Cells were fixed in formaldehyde using a final concentration of 2% formaldehyde. Reactions 
were stopped using 2.5 M glycine. Cells were frozen at -80°C until sufficient numbers for 
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performing ChIP were collected. Cells were lysed in cell lysis buffer (10 mM Tris-HCl, 10 mM 
NaCl, 0.2% NP40, 10 mM sodium butyrate, 300 uM PMSF, 1x complete protease inhibitor). 
Nuclei were pelleted and lysed with nuclear lysis buffer (50 mM Tris-HCl, 10 mM EDTA, 1% 
SDS, 10 mM sodium butyrate, 300 uM PMSF, 1x complete protease inhibitor). Cells were 
sonicated on ice with ChIP IP dilution buffer (20 mM Tris-HCl, 2 mM EDTA,150 mM NaCl, 
0.01% SDS, 1% Triton X-100, 10 mM sodium butyrate, 300 uM PMSF, 1x complete protease 
inhibitor). Lysates were pre-cleared using preimmune rabbit serum and immunoprecipitation was 
performed overnight at 4°C. Antibodies used were H3K27me2me3 (Active Motif, Carlsbad, CA) 
and control IgG (R&D Systems, Minneapolis, MN). Protein A Agarose beads were added to 
immunoprecipitate antibody-protein-DNA complexes. Crosslinking was reversed using 5M NaCl 
overnight at 67°C and nucleic acids were purified using phenol-chloroform extraction. 
Recovered DNA was analyzed by qPCR using primers specific for the promoter regions of IL-
12b gene.  
Calculations and statistics 
Statistical significance was calculated using Student’s t-test for individual paired comparisons or 
t-test with Bonferoni adjustment, whenever multiple groups were compared. Means with P-
values of < 0.05 were considered significantly different and were represented by *. P-values of < 
0.01 were represented by ** and P-values of < 0.001 were represented by ***. All values are 
reported as means ± standard errors (SEM). Calculations were performed using Prism of 
GraphPad software (La Jolla, CA). 
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Results 
Transient TNFα depletion leads to increased chronic fungal burden and higher levels of 
Th2-associated cytokines. 
To determine how TNFα depletion affects fungal clearance, we analyzed fungal burden 
and Th2 cytokine expression levels. CBA/J mice were infected intratracheally with Cryptococcus 
neoformans strain 52D and either received TNFα blocking antibody (anti-TNFα) or an isotype 
control antibody injected intraperitoneally at the time of infection. Colony forming units (CFU) 
from harvested lung and spleen were evaluated for both treatment groups at 1, 2 and 4 weeks 
post-infection (wpi). TNFα depletion did not change pulmonary fungal burden at week 1, but led 
to an increased fungal burden in the lung at weeks 2 and 4 (Fig. 1A). Anti-TNFα mice had 
progressive dissemination to the spleen, while the dissemination in control mice was transient 
and minimal (Fig. 1B), together suggesting that TNFα is critical early in the immune response 
for protective clearance of the pathogen, while its absence results in a non-protective response.  
  Because a switch from the protective Th1 response to a non-protective Th2 could account 
for the loss of protection that followed transient depletion of TNFα, we next examined 
involvement of Th2 cytokines. Serum cytokine levels from both treatment groups were evaluated 
using a cytometric bead array. Mice that recieved anti-TNFα treatment had increased levels of 
non-protective cytokines IL-13 and IL-5 compared to the control group throughout infection 
(Figs. 1C-D). This prolonged non-protective immune response marked by elevated systemic 
levels of Th2 cytokines in the anti-TNFα mice strongly suggests that in the absence of early 
TNFα signaling, mice deviated to a Th2 –type immune response.  
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Figure 1 - Mice were infected intratracheally with 104 CFU of C. neoformans. Harvests were 
performed at 1, 2 and 4 weeks post infection (wpi). Fungal burden was assessed from harvested 
lung and spleen from mice treated with isotype control and mice treated with anti-TNFα upon 
infection (n = 4) (Figs. 1A-B). Cytometric bead arrays were performed using blood serum 
isolated from CBA/J mice (n = 7) (Figs. 1C-D). Data represent mean pooled from three separate 
matched experiments. * p < 0.05, ** p < 0.01 between indicated groups.  
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Mice depleted of TNFα display a Th2 response, which is preceded by DC2 activation of 
pulmonary DCs.  
To determine if the absence of TNFα signaling resulted in bona fide change in T-cell 
polarization, we assessed how early TNFα depletion affected subsequent CD4 T-cell polarization 
status in the infected lungs. We analyzed polarization in magnetically separated CD4+ T-cells by 
measuring mRNA expression of key Th1/Th17 cytokines. T-cells were magnetically separated 
from lung leukocytes isolated from mice infected with C. neoformans that were either TNFα 
depleted using the blocking antibody or received an isotype control. TNFα depletion led to a 
decrease in the Th1 master transcription factor T-bet and decreased expression of Th1 and Th17 
associated cytokines (IFNγ, IL-17, IL-23) (Fig. 2A). Thus in the absence of TNFα, T-cell 
polarization is skewed towards the non-protective Th2 polarization at 2 wpi. Because DCs prime 
T-cells in both the lymph node and the lung, this suggested to us that DCs responsible for T-cell 
priming may be different in the presence or absence of TNFα. Next, we assessed DC1 and DC2 
gene expression from mRNA extracted from CD11c+ cells magnetically isolated from infected 
mouse lung. Treatment with the TNFα blocking antibody led to decreased levels of DC1 marker 
iNOS and increased levels of DC2 marker Arginase (Fig. 2B), whereas the control mice had 
increased iNOS and decreased Arginase expression. To confirm DC1/DC2 polarization at the 
protein level, we performed flow cytometry on pulmonary DCs isolated from infected lungs at 1 
wpi. DC1 cells are characterized by higher surface expression of MHCII and co-stimulatory 
molecules than DC2 cells. We found that MHCII expression and co-stimulatory molecule 
expression of CD86 was decreased on the surface of DCs from anti-TNFα-treated mice relative 
to control mice (Figs. 2C-D). This supported our hypothesis that TNFα-depletion resulted in 
DC2 polarization rather than DC1, which preceded the differential polarization of T-cells.  
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Figure 2 
 
Figure 2 –Leukocytes were isolated through enzymatic digestion of whole mouse lungs from 
mice at indicated time points (n = 8). CD4+ cells were isolated by magnetic bead separation at    
2 wpi, preserved in Trizol, and levels of mRNA for various Th1 associated genes were evaluated 
using qPCR (Fig. 2A). CD11c+ cells (primarily DCs) were isolated using magnetic bead 
separation and analyzed for levels of Th1 and Th2 associated signaling molecules at 2 wpi            
(Fig. 2B). Mean fluorescence intensity (MFI) surface staining of lung leukocyte populations and 
flow cytometric analysis was used to measure MHCII surface protein (Fig. 2C) or CD86 
costimulatory molecule surface expression (Fig. 2D) levels of DCs from each treatment group    
(n = 6-8). Data represent pooled data from 2-4 separate, matched experiments. Dotted black line 
represents MFI of uninfected, untreated control mice. * p < 0.05, *** p < 0.001 between 
indicated values. 
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TNFα promotes lasting suppression of DC2 associated genes and stabilizes DC1 gene 
expression in DCs in vivo despite exposure to IL-4. 
We next used in vitro methods to further explore the mechanism of DC polarization. We 
developed a system of cytokine cycling experiments to determine the role of TNFα on Bone 
Marrow-derived Dendritic Cells (BMDCs) (Fig. 3). In these experiments, BMDCs are cultured 
and matured for 7 days in the presence of GM-CSF, plated, and stimulated with DC1 polarizing 
cytokine IFNγ alone or in combination with TNFα, which comprises the “training phase.” After 
24 hours, the cytokine environment is either switched to the DC2 polarizing cytokine IL-4, or re-
stimulated with IFNγ, for the “challenge phase.”  
To explore the affects of TNFα on DC polarization in vitro, we analyzed levels of key 
DC2 marker genes Gal3, Fizz1, IL-13 and DC1 marker genes iNOS and IL-12b (Fig. 4). DCs 
exposed to IFNγ alone or in combination with TNFα during the training phase and IFNγ alone 
during the challenge phase had a DC1 gene expression profile characterized by low Fizz1, low 
Gal3, low IL-13, high iNOS and high IL-12b. DCs stimulated with IFNγ alone and challenged 
with IL-4 had increased levels of Gal3, Fizz1 and IL-13 indicating a DC2 polarization. However, 
when DCs were stimulated with IFNγ in the presence of TNFα, DC2 gene levels remained 
consistent with the DC1 primary stimulation phenotype after they were challenged with IL-4. 
This indicated that in the absence of TNFα, DCs are unable to resist changes to their DC2 
polarization. 
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Figure 3 - Cytokine cycling experiment schematic.  Bone marrow-derived dendritic cells 
(BMDCs) were collected from the bones of uninfected CBA/J mice and cultured over 7 days in 
the presence of GM-CSF to preferentially develop DCs. At day 7, the loosely-adherent fraction 
was harvested and plated. Cells were cultured in the indicated cytokine environments for 24 
hours, washed, and given another 24-hour cytokine stimulation. 
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Figure 4 - Cells were cultured and harvested using the above schematic. mRNA was extracted 
from each group and data pooled from at least 3 experiments, each with 3 wells of the same 
treatment group. Levels of Th2 (Gal3, Fizz1, IL-13, Figs. 4A-C) and Th1 (iNOS, IL-12b Figs. 
4D-E) associated genes were analyzed using qPCR (Figs. 4A-E). * p < 0.05, ** p < 0.01,               
*** p < 0.001 between the indicated treatment groups. 
 
 
Expression of repressive modification H3K27 trimethylation is increased in vivo upon 
treatment with anti-TNFα antibody. 
We then proceeded to explore the epigenetic controls to key DC genes in the DC training 
process. To assess global epigenetic differences between DC1 and DC2 cells, we measured 
H3K27me3, which is a repressive modification, in lung DCs by intranuclear flow cytometry 
(Fig. 5A-B). Quantification of histogram results show a near-significant trend (p= 0.052) towards 
higher mean fluorescence intensity representing the repressive H3K27me3 modification in pre-
DCs (monocytes) in the lungs of anti-TNFα treated mice at 1 wpi (Figs. 5C). This motivated 
more robust analysis of the percentage of cells highly enriched with the repressive H3K27me3 
signature. Analysis revealed that TNFα depletion increased the percentage of DCs expressing 
high global H3K27me3 signature in C. neoformans infected lungs (Figs 5D-E). This signifies a 
difference in epigenetic modification to the H3K27 residue in the presence or absence of TNFα 
signaling. The increased presence of H3K27me3 in samples treated with anti-TNFα indicates the 
higher level of repressive epigenetic signature when the cytokine is depleted.  
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Figure 5 – Flow cytometric analysis of lung DCs at 1 and 2 wpi. Cells were fixed, permeablized, 
and intranuclear flow cytometry was performed for the histone modification H3K27me3. Data 
presented as representative histograms (Fig. 5A) and MFI (n = 6-8, Figs. 5B-C) shows that in the 
absence of infection, there are no substantial differences in the H3K27me3 signature of the DCs 
with (blue) and without (red) TNFα (yellow indicates intranucler isotype antibody staining). 
However, during infection, DCs in the absence of TNFα have a more pronounced H3K27me3 
signature assessed by MFI (Fig. 5C) and by percent of cells with enriched H3K27me3 at multiple 
time points post-infection (Figs. 5D-E). ** p < 0.01, *** p < 0.001 between indicated groups. 
 
 
TNFα reduces levels of gene expression of histone methyltransferase EZH2 in BMDCs, and 
treatment with anti-TNFα leads to upregulated expression of EZH2 upon infection in vivo.  
Because the level of H3K27me3 was increased in DC2 polarized DCs, we assessed 
expression of EZH2, a major component of the PRC2 complex, which is a key H3K27 
methyltransfersase in vitro and in vivo. DCs matured in vitro in the presence of TNFα and IFNγ 
had uniformly low expression of EZH2 regardless of challenge with IL-4, consistent with a DC1 
phenotype; however, cells matured without TNFα (IFNγ alone) and challenged with IL-4 had an 
upregulation of EZH2, which correlates with the DC2 phenotype (Fig. 6A). In vivo, DCs from 
the lungs of C. neo infected mice that were TNFα-depleted had likewise significantly more 
EZH2 mRNA expression than DCs from infected control mice (Fig. 6B). This data corresponded 
to our H3K27me3 data, suggesting that EZH2 upregulation leads to higher methylation at 
H3K27, and that this happens in DC2-polarized cells. 
 27 
Figure 6 
 
 
 
 
 
 
 
 
 
 
Figure 6 – BMDCs were collected from the bones of uninfected CBA/J mice. Cytokine cycling 
experiments were performed using the method described in Figure 3. mRNA was extracted from 
each group and data was pooled from 2 experiments, each with 3 wells of the same treatment 
group. Levels of EZH2 were analyzed using qPCR (Fig. 6A). For our in vivo studies, CD11c+ 
cells were magnetically separated from lung leukocytes isolated from mice at 1 wpi (n = 4-8). 
EZH2 gene expression was evaluated using qPCR (Fig. 6B). Data represent pooled data from 3 
separate, matched experiments. ** p < 0.01, *** p < 0.001 between indicated groups. 
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TNFα prevents repressive modification H3K27me3 at DC1 gene promoter otherwise 
induced by IL-4. 
Because both H3K27me3 and the H3K27 methyltransferase complex were increased in 
cells with a DC2 phenotype, we next assessed whether the repressive H3K27me3 modification 
was associated with DC1 gene promoters in DC2s. We performed ChIP-PCR and using 
H3K27me3-specific antibodies to immunoprecipitate the histone-DNA complexes and using 
primers specific to the promoter region of IL-12b. We found that in cells matured in vitro with 
IFNγ that were challenged with IL-4 (phenotypically DC2 cells), there was an increase in the 
amount of IL-12b promoters associated with the repressive H3K27me3 (Fig. 7), indicating that 
the IL-12b promoter is epigenetically silenced in DC2 cells. However, DCs matured with IFNγ 
and TNFα that were subsequently challenged with IL-4 did not have IL-12b associated with the 
H3K27me3. Thus, in the absence of TNFα, DC2s have epigenetically repressed DC1 genes, but 
in the presence of TNFα, the IL-12b promoter becomes protected from this repression (effect 
associated with corresponding differences in the expression of H3K27 methyltransferase EZH2). 
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Figure 7 
 
 
 
 
 
 
Figure 7 – BMDCs were collected from the bones of uninfected CBA/J mice. Cytokine cycling 
experiments were performed using the method described in Figure 3. Chromatin 
Immunoprecipitation Assay was performed using anti-H3K27me3 antibodies. Resulting DNA 
was purified and qPCR was performed using primers specific for the promoter region of IL-12b. 
* p < 0.05 between indicated groups. 
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Discussion 
 These studies have indicated that TNFα plays a crucial role in modulating epigenetic 
changes to H3K27 residues in DCs during fungal infection and in programming the immune 
response. This is the first report of this type made in a fungal infection. 
 TNFα depletion profoundly impaired fungal clearance during the adaptive immune 
response. Both lung and spleen fungal burdens were over 100-fold higher in mice treated with 
anti-TNFα antibodies, which depleted TNFα signaling during the early stage of infection. Our 
results are consistent with previous studies, which have shown that early TNFα is required for 
generation of the immune protection against C. neoformans [28-31]. Our data show the crucial 
role of TNFα in programming the immune response, especially in prevention of non-protective 
skewing to a Th2 phenotype. Serum harvested from infected mice showed that type 2 cytokines 
are found in significantly higher levels in infected mice depleted of TNFα as compared to mice 
that did not receive treatment. Because levels of IL-13 and IL-5 were significantly higher in anti-
TNFα treated groups, we can see that TNFα signaling “programs” the development of the 
desirable type of immune response, while in its absence the immune system becomes 
“programmed” for development of a non-protective response. Although levels of TNFα recover, 
the fungal burden remains significantly lower in anti-TNFα treated mice at 2 wpi and beyond 
[15]. This led us to hypothesize that early TNFα could induce or prevent certain epigenetic 
modifications, which in turn could support or repress expression of genes responsible for the 
development of the desirable Th1 immunophenotype.  
 T-cell polarization during C. neo infection in the absence of TNFα was consistently 
skewed towards a non-protective Th2 response. TNFα depletion lead to decreased levels of Th1 
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associated cytokines, indicating that TNFα is necessary to prime a protective immune response. 
In other models of fungal infection in the absence of TNFα, including Candida albicans, 
Aspergillus fumigatus, and Paracoccidioides bransiliensis, neutrophils have been shown to be a 
critical cell population for clearance [30]. However, the effects of TNFα depletion have been 
shown to be independent of neutrophil action during C. neo infection [30]. This suggests that 
another mechanism occurs to boost host defenses and leads to fungal clearance of C. neo. We 
chose to explore the alternate possibility of TNFα priming of DCs in a way that enables them to 
orchestrate protective Th1 T-cell polarization.  
 Our cycling experiments show that TNFα “trains” DCs to sustain protective DC1 
programming acquired during their initial stimulation with IFNγ and prevent their switch to DC2 
phenotype during subsequent stimulation with the strong pro-DC2 factor, IL-4. DCs resisted 
DC2 gene induction after replacement of IFNγ by IL-4 only when TNFα was present during the 
initial stimulation. This indicates that TNFα stabilized DC1 programming induced by IFNγ, 
while its absence allowed DCs to remain prone to switching to DC2. Depletion of TNFα results 
in DCs of increased plasticity to their cytokine environments.  
 Our studies show that during cryptococcal infection, DCs show enhanced expression of 
major histocompatibility complex II  (MHCII) and various co-stimulatory molecules (CD40, 
CD80, CD86) [49]. Mature DCs also produce a variety of cytokines (IL-12, IL-6, IL-4, IL-13, 
and TGF-β), which in turn program T-cell polarization [50]. Among these molecules, robust 
expression of MHCII and IL-12 are necessary for the priming of T-cells into Th1 cells by DCs 
[16-18]. Because priming of DCs into DC1s has been shown to be critical for the development of 
a protective Th1 response against C. neo, our data indicate that initial depletion of TNFα may 
inhibit this process [30]. Inhibition of DC1 development could be related to either delayed 
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maturation of DCs or the development of DC2 phenotype in place of DC1. Our data demonstrate 
that blocking TNFα in vitro, even in the absence of infection, may prime DCs towards DC2 
rather than DC1. This contradicts previously postulated mechanisms for the development of 
immature DCs that suggest DC2 polarization by diminished expression of MHCII [14].  
Diminished MHCII expression, however, may characterize both immature DCs and DC2.  Our 
novel data (in vitro and in vivo) show that the absence of TNFα signaling enables upregulation 
of DC2 signature by DCs in addition to diminished expression of MHCII. Examination of key 
DC2 genes, including Gal3, Fizz1, and IL-13, demonstrates that the absence of TNFα leads to 
formation of DC2s. This represents a critical step in the understanding more about basic DC 
biology.  
 Because DC1s and DC2s exert differential long-term effects on host responses, we 
hypothesized that epigenetic gene regulation would be different between these two cell types, 
similar to differential epigenetic regulation observed in macrophages [51-53]. Consistent with 
this hypothesis, we observed higher levels of repressive modification H3K27me3 in DCs from 
mice that received anti-TNFα treatment as compared to untreated mice. This indicates that in the 
absence of TNFα, DCs from infected mice may show enhanced levels of repressive epigenetic 
modifications compared to mice that developed protective immune response with the help of 
endogenously induced TNFα. Consistently, TNFα signaling resulted in downregulation of 
histone methyltransferase EZH2, which is responsible for H3K27me3 (Fig. 5). Pervious work 
has shown that TNFα can signal to EZH2 using the MAPK pathway, specifically p38α [48]. 
EZH2 is being increasingly investigated for its role in cancer, and its inhibitors are currently 
being tested in tumor therapy [44]. Based on our studies, inhibition of EZH2 could also be 
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beneficial for clearance of C. neo infection, and we anticipate that such therapy may eventually 
become possible.  
 Our group has also explored the potential activating epigenetic modifications observed 
during the tri-methylated state of H3K4. Data not shown in this paper indicate that in vitro, levels 
of the H3K4 histone methyltransferase MLL1 in BMDCs increase upon addition of TNFα. 
Additionally, DCs isolated from the lungs of infected mice showed decreased levels of MLL1 in 
the absence of TNFα on day 7 post-infection. The increase in MLL1 transcript levels 
corresponds to increased global tri-methylation of H3K4 in the lungs of infected mice on day 7 
post-infection. Because H3K4me3 is associated with gene activation [42], increased expression 
of MLL1 suggests that TNFα promotes the priming of DC1 through epigenetic modifications. 
These results fit with our hypothesis of the effects of TNFα on dendritic cells, which occur with 
both repressive (H3K27me3) and activating (H3K4me3) epigenetic signatures.  
 While global increase in H3K27me3 could affect multiple genes, we were interested in 
major genes involved in DC signaling that lead to successful development of type 1 immunity. 
IL-12 is one of the most important signals leading to the development of the protective Th1 
response. Our preliminary data from in vitro ChIP experiments show significant enrichment of 
H3K27me3 at the promoter of gene IL-12b in absence of TNFα signaling. While further 
experiments are necessary to determine the baseline epigenetic state in DCs and how TNFα plays 
a role in the epigenetic regulation process in vivo, our in vitro data are consistent with notion that 
TNFα prevents suppressive trimethylation at the promoter region of IL-12 gene. 
 In summary, this work has explored the role of pro-inflammatory cytokine TNFα in the 
polarization of DCs in the context of infection of the opportunistic fungal pathogen, 
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Cryptococcus neoformans. Although extensive work has been done regarding the importance of 
TNFα early in infection, the exact mechanism has been poorly understood and presumed defect 
in DC maturation. We demonstrated that TNFα prevented detrimental DC2 polarization, 
interfering with the repressive epigenetic modification H3K27me3. Specifically, we have shown 
that in absence of TNFα, promoters of key DC1 gene IL-12b were epigenetically repressed via 
this motif. These data shed a light on the mechanisms by which DCs polarize upon infection, 
which may have broader implications for understanding mechanisms of host defenses for a wide 
variety of fungal pathogens and may lead to the development of therapeutic targets in the future.  
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